Favourites
Have ideas?
Sign in
/
Register
Positive
:
Negative
:
Hepatitis segment
ABUS
Arbutus Biopharma Corporation - Common Stock
11.06%
11.06%
0
+
Biopharma
,
Medicine
,
Hepatitis
Last highlighted: #ABUS SEC report: Arbutus Biopharma Corp Quarterly report [Sections 13 or 15(d)]
SEC Filing Form 10-Q filed by Arbutus Biopharma Corp -- SEC File Number 211148337
+ My List
ALGS
Aligos Therapeutics, Inc. - Common stock
6.84%
down 7.34%
-0.5
+
Medicine
,
Hepatitis
Last highlighted: #ALGS SEC report: Aligos Therapeutics, Inc. Current report, items 2.02 and 9.01
SEC Filing Form 8-K filed by Aligos Therapeutics, Inc. -- SEC File Number 211148130
+ My List
COCP
Cocrystal Pharma, Inc. - Common Stock
7.21%
up
5.41%
1.8
+
Medicine
,
Hepatitis
,
COVID
,
Covid (fighting)
+ My List
We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.